Pfizer gets approval for $43 billion deal with Seagen after donating rights to cancer drugs

Pfizer said it expects to close a $43 billion deal to buy cancer drug maker Seagen later this week and plans to create a new oncology division that includes an acquisition early next week.

Share This Post: